Shelton Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,316
Closed -$410K 734
2020
Q1
$410K Hold
2,316
0.03% 329
2019
Q4
$443K Sell
2,316
-301
-12% -$54.3K 0.02% 393
2019
Q3
$440K Hold
2,617
0.03% 384
2019
Q2
$438K Buy
2,617
+2,234
+583% +$309K 0.03% 383
2019
Q1
$2.62K Sell
383
-2,234
-85% -$324K 0.01% 760
2018
Q4
$350K Sell
2,617
-200
-7% -$32.8K 0.02% 412
2018
Q3
$537K Hold
2,817
0.03% 344
2018
Q2
$470K Sell
2,817
-900
-24% -$144K 0.03% 371
2018
Q1
$626K Sell
3,717
-400
-10% -$67.1K 0.04% 311
2017
Q4
$673K Hold
4,117
0.04% 299
2017
Q3
$844K Buy
4,117
+1,077
+35% +$250K 0.06% 260
2017
Q2
$739K Buy
3,040
+10
+0.3% +$2.35K 0.05% 275
2017
Q1
$724K Sell
3,030
-125
-4% -$29.1K 0.05% 275
2016
Q4
$663K Buy
3,155
+125
+4% +$25.9K 0.05% 300
2016
Q3
$698K Sell
3,030
-125
-4% -$30.5K 0.06% 277
2016
Q2
$729K Buy
3,155
+100
+3% +$23.1K 0.06% 268
2016
Q1
$819K Hold
3,055
0.07% 235
2015
Q4
$955K Buy
3,055
+125
+4% +$37.2K 0.09% 198
2015
Q3
$796K Hold
2,930
0.09% 211
2015
Q2
$889K Buy
2,930
+826
+39% +$246K 0.09% 204
2015
Q1
$626K Sell
2,104
-2,993
-59% -$853K 0.07% 301
2014
Q4
$1.31M Hold
5,097
0.15% 130
2014
Q3
$1.23M Buy
5,097
+3,808
+295% +$852K 0.17% 124
2014
Q2
$288K Hold
1,289
0.04% 581
2014
Q1
$265K Hold
1,289
0.04% 590
2013
Q4
$217K Buy
+1,289
New +$202K 0.03% 667

Other funds holding AGN

Shelton Capital Management's AGN Position: Q2 2020 in Review

Shelton Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,316 shares — an estimated $410K sold.

Shelton Capital Management first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $1.31M in Q4 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Shelton Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Shelton Capital Management sold 2,316 Allergan plc shares in Q2 2020, an estimated $410K.
  • Shelton Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Shelton Capital Management's Allergan plc position peaked at $1.31M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Shelton Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.